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1 INTRODUCTION 
South Africa is in the midst of a HIV/AIDS crisis of catastrophic propor-
tions, Although the exact figures are in dispute, I most experts agree that 
between four and six million people in South Africa are presently living 
with the HIV virus and that this figure will keep rising for the next five 
years.2 According to a recent report prepared by the Medical Research 
Council of South Africa (MRC), over half the deaths of people between the 
ages of 15 and 49 have HIV/AIDS-related causes. A disproportionate 
number of those affected by HIV/AIDS are marginalised because they are 
female, black, poor, or livin~ in rural areas, or - often - because of a 
combination of these factors. The more marginalised and vulnerable the 
1 See for example, iafrica.com 2001 "We are proud of AIDS report - MRC' 
< hllp:lJiafn,tl.('om/nnvs/sa/82-1094.htm > Accessed J 2 February 2002; sabcnews.com 
2001 "MRC stands by its controversial AIDS report" < www.sabcnews.com/ 
south_africa/health/O. /009.22JO 1.00.html > Accessed 9 February 2002: Independent On-
line 2001 "AIDS impact difficult to gauge, says SlatS SA" <www.iol.co.za/ 
index.php?C/ick_id = I 25&arUd = ct200 110 120942J2225S32079&seud = I > Accessed 9 
February 2002. See also MedICal Research Council (MRC) of South Africa 2001 "The im-
pact of HIV/AIDS on adult mortality in South Africa" < www.mrc.ac.za/bod/index.htm > 
Accessed 1 I November 200 I. 
2 The Actuarial Society of South Africa (ASSA) model on AIDS estimates that in 2002 6.5 
million South Africans will be infected with the HIV virus and that this figure will in-
crease to 7.7 million by 2006 if no intervention is made. If modest interventions are 
made the total HIV infection in 2002 will be 6.49 million and in 2006, 6.99 million. 
ASSA 200 I "Actuarial Association of South Africa HIV/AIDS model" < www.assa.org.zal 
committees/AIDSlsummarystats.htm> Accessed t 5 November 200 I. The Depanment of 
Health estimates that 4.7 million South Africans were infected With the HIV virus in 
200 I. Depanment of Health 200 I a "National HIV and syphilis sero-prevalence survey of 
women attending public antenatal clinics in South Africa" < hUp.//196.36.15J.56/ 
dohIAIDS/index.html> par 4. I .4. Accessed 10 November 2001 . The MRC mak.es similar 
findings, staring thar between 5 and 7 million South Africans will die of HIV-related 
causes by 200 I. M RC 200 I , supra note I. 
3 By the time a Soulh African woman is 22 years old, for example. there is a 24 % chance 
that she has contracted the HIV virus or has developed AIDS. This is born out by statis-
tics provided by (he Depanment of Health, which estimates tllar almost a quarter of all 
pregnant women using public health facilities in 2000 lived with HIV/AIDS. See Depart-
ment of Health (200 I a), supra note 2, at par 4.1.1, stating that 24.5 % of all pregnant 
[conrinued on next page] 
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LAW, DEMOCRACY & DEVELOPMENT 
group, the more at risk they appear to be of contracting HIV/AIDS. This 
claim is born out by the state's own HIV/AIDS/STD Strategic Plan, which 
states that the HIV/AIDS epidemic is severely affecting the young, black 
and economically poor in South Africa.' 
In the face of such an overwhelming crisis, the state and other role 
players clearly have a constitutional duty to take all reasonable steps to 
address the crisis. This duty to act stems from the state's constitutional 
obligations to protect the right to life and human dignity," to provide 
access [0 health care services' and to protect everyone from discrimina-
tion on grounds of race, sex, gender, sexual orientation. marital status. 
age or social origin." It is difficult. however. to state with any degree of 
certainty exactly what steps the state is constitutionally required to take. 
The HIV/AIDS crisis has confronted the state with a complex set of prob-
lems of enormous magnitude and it clearly necessitates an integrated and 
holistic response. To be effective. the state response should address an 
array of issues. including steps to: 
• ensure the prevention of HIV transmission;" 
• provide adequate and effective treatment. care and support for people 
living with HIV;' 
WOlllen w,illg public Ilealth laullties ill 2000 are estimated to be living with IIiV/AIDS 
WOllle11 are, of Lourst'. partlculilrly at risk As Albl'rtyn has arguer!, not only are women 
physiologically at grealer risk 01 HIV IranSITlISSIOI1, tJ(J( their "lack of power over their 
bodies all(! their sexlIill lives. supported a IlL! reinlorced by their social and economic 
inequality 11Iakl,ls] thelll SUCll a vulilcrable group in cOrHracting. illlt! IIVilig Wilh, 
IIiV/AIDS'" AIIll'rtyn C 2000 '"Using rlgilis iHH! Ihe law 10 reduce women's vulnerabililY 
10 IlIV/AIDS: A discussion paper'" < www.AIDSI1lw.caltluruan20()()/womenjinalpd/> 
Accessed 9 Novemher 200 I p. I. 
'\ ()epartlTlcnt of Ilealill 200la, supra Ilote 2. at 8. 
o, The ( onSlilUlion of Ihe Republic of Sowh Alrica An 10801 1l)')6, s I I 
(, Iflid s 10 
7 I/}id s 27( I )(a) 
8 luid s 'J(3) 
9 In order 10 bE, eiif'CIIVe such a prevenlative programme sllouid indur!e a culturally 
appropriate and sensilive but hOllest and direct callipaign to address the popula-
tion's sexual behaviollr. It should also include policies alld programlTles to provide dllti-
relroviral drugs to ill(1ividuals exposed to IIIV intectioll througtl sexual assiHtlt and 
medical proCiodun,s. While the first dSpect lTIenlioned above falls o(J(side the slope of 
tltis article, Itle secone! aspect is dealt with below. 
10 This paper deals with only one aspeci of the provision of adequate treatment and care. 
nailicly tile provision of anti-retroviral drugs to indivitlltdls li\'ing wilh HIV. However. 
tilis is by no llIeans the only illlportdnt treiwnenl isslIe wilell it collies to measuring 
wllf'tiler Ihe governlllent rf'sponse was adequdte alld appropriate. First. individllals liv-
ing wiltl IIIV olten require ilCCl~SS to IreatlTlent for opportunistic infeclions caused or ex-
acerbated by a weakened inHllUIl(; syslelTl. This lTleans that an individllal needs access 
to other nWl1icine like acylovir, cotrimoxazole or fllIconazole designed 10 treat sylllp-
tOlns often associatel1 with living with AIDS. According 10 tile policy guidelines issued 
by Ilw Departillent of Hcalttl ill August 2000. it is governlnellt policy to treat suctl op-
portunistic infections and. in serious cases, to admit SUeil patients to slate ilospitals 
where appropriale. Sec Dcpartmellt or Ilealtll 2000a "'"V/AIDS Policy guidelines: 
84 
Prevention an(1 trealment of Opportlillistic and IIIV-reialed diseases in adults" Augusl 
12 11. Ilowever. lor a variety ot reasons ITldny individuals fail to gain access 10 treat-
nlellt prescribed ily tilt UcpartlTlerH. SeCO[lti, people Ilvilig with HIV/AIDS anr! needing 
{continued on next fJa!lc] 
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SO MUCH TO DO, SO UTILE DONE 
• ensure the effective protection of people living with HIV against dis-
crimination and abuse;" and 
• ensure the adequate tracking of the spread of HIV. 
Although it is highly desirable that the state aggressively pursues all these 
avenues to the best of its capability, the legal question is whether the state 
is constitutionally reqUired to take certain prescribed steps. Embarking on 
such an enquiry would be a gargantuan task. It is beyond the scope of this 
article to evaluate the state's HIV/AIDS strategy - which purports to en-
gage with all the above-mentioned aspects - in its entirety. Instead, I shall 
focus on one aspect of this strategy, namely the state's poliCies and prac-
tices in providing alJ people with access to anti-retroviral drugs, first, to 
prevent individuals from becoming HIV positive and, second. to inhibit 
the spread of HIV in HIV positive individuals. Given the complex and 
interrelated nature of any adequate response to the HIV/AIDS crisis this 
distinction is somewhat artificial, but it is impossible to address all these 
extremely complex and important issues in the limited space available 
here. I choose to focus on access to anti-retroviral drugs because in the 
face of the overwhelming crisis, the administering of such drugs in differ-
ent settings can save countless lives and can indefinitely prolong the lives 
of countless others. Although they do not destroy the HIV virus and can-
not be considered as a cure for the virus, anti-retroviral drugs correctly 
administered - hold out the promise of hope to millions of South Africans 
who live with HrV. 
In order to determine the scope of the state's constitutional duty to pro-
vide access to anti-retroviral drugs, I endeavour, first, to sketch the basic 
facts about HIV/AIDS and the possible uses of anti-retroviral drugs in its 
prevention and treatment. Second, I set out the Constitutional Court's 
jurisprudence on social and economic rights as it relates to access to 
health care. Third, I set out and evaluate the state's policies and practices 
regarding the uses of anti-retroviral drugs to establish whether it is fulfill-
ing its constitutional duties in this regard. 
2 HIV/AIDS AND ANTI-RETROVIRAL DRUGS 
HIV/AIDS is a progressive disease of the immune system that is caused by 
the Human Immunodeficiency Virus (HIV)." HIV is transmitted through 
treatment in state medical institutions should have access (0 care of an appropriate 
quality. Due [0 a lack of trained staff, of facilities and of leadership at many state hospi-
tals, such care is often not available. 
II This aspect will not be dealt with in this paper. In terms of the framework, this 
aspect of HIV prevention is probably the one in which tile government Ilas Ilad most 
success due to the Constitutional prohibition against discrimination. See for example 
Halfmann v South African Airways 2000 (I I) BCLR 121 I (CC), wllere tile Constitutional 
Court found that differentiation on the baSis of HIV status constituted unfair discrimina-
tion in terms of s 9(3) of the Constitulion. 
12 See Department of Health 2000b "HIVlAIDSlSTD StrategiC plan for South Africa 2000-2005," 
ch 5. See also Department of Health 200 I b "The South African government's response to 
the HIV/AIDS epidemic: Controversies and priorities" < http://196.36.153.56IdohlAIDS/docs/ 
gov-AIDShtml> Accessed 16 November 200 I. 
13 Morgan et al (200 I. 143-145). It might seem superfluous (Q provide footnote references 
for this almost universally accepted statement, but due to the scepticIsm expressed by 
[continued on next page] 
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LAW. DEMOCRACY & IJEVELOPMENT 
intimate contact involving the exchange of bodily fluids, including expo-
sure to or reception of contaminated blood, fluids produced during sexual 
intercourse, fluids produced during childbirth, and mothers' milk. All 
available scientific evidence (endorsed by the Constitutional Court)" 
points to the fact that HIV is a human retrovirus that affects essential 
white blood cells, erodes the immune system and eventually leads to its 
complete deterioration. This progression of HIV is generally divided into 
four stages. During the first stage, called the acute stage, the individual 
contracts the virus and experiences flu-like symptoms. In the second 
stage, called the asymptomatic immunecompetent stage, the individual is 
HIV positive but the number of CD4 + lymphocytes (white blood cells) 
that are being attacked by the virus is still above 500 cells per micro litre 
of blood. During the third stage, called the asymptomatic immune-
suppressed stage, the CD4 + counts dips below 500 cells per micro litre of 
blood. In the last stage, called AIDS, the CD4 + count drops below 350 
cells per micro litre of blood and the individual becomes vulnerable to 
opportunistic infections.'" At this fourth stage an individual is said to have 
contracted AIDS because his or her immune system is so profoundly 
depleted that the individual becomes prone to opportunistic infections 
that may prove fatal because of the body's inability to fight them.,n 
However, steps can be taken to limit the risk of infection. They include 
the use of condoms during sexual intercourse, the early treatment of other 
sexually transmitted diseases, the administration of anti-retroviral drugs 
after exposure to the H1V virus due to medical accidents, rape or sexual 
assault, and strategies to reduce the transmission of HIV from HIV positive 
mothers to their children.'"! Such strategies include - but are not limited to 
- various options regarding the provision of anti-retroviral drugs to moth-
ers before and during labour and to babies shortly after birth. '" 
Once infected, the majority of people living with HIV/AIDS will die pre-
maturely of illnesses that destroy their immune system, their quality of 
life and their dignity. However, the life of a H1V pOSitive individual can be 
prolonged and his or her quality of life improved by ensuring early diag-
nosis, clinical management, the medical treatment of opportunistic infec-
tions and the appropriate use of anti-retroviral therapy.'4 Opportunistic 
I'residelll Tliabo Mbeki aboul Ihe lin" betwcell IlIV dllcj AlllS it is essential to delllon-
Slrate that the basic facts about IlIV/AiDS are 1101 in dispule. In the legal sense. tilis is 
not diflicult because SOlllh Africa's (ollslilulional COlrrt lias endorseci these basic facts 
in Ilulflndnn. supra note I I. pM I I 15. 
11 Ilofllllallnluid. 
15 IlJ/d par II 
I () J/J/d. 
17 llepartlTwllf 01 Healtli 200 I b. supra note 12. pM I I. 12: I 3. 
I H See Conllor 1'1 (/1 1991; I.indegren et 01 1')99: Guay et (/1 1999. 
I ') Sec IJS Heallh dnd HllIllall Services 200 I "C;lIidelilws for the lise 01 anI i-retroviral agents 
ill HIV-infccred adults alld adulescents" < www.hlvol/s.or!J> Accessed 3 February 2002; 
f'alella PI III 199H. TIIC I)epartlllcnt of llealtll agrees with this statement. See lJepart-
Inell! of I !tall 11 2000a: 9. supra nOll' 10: "Current research strongly Inclicates that sup-
pressing IIIV vir,ll activity and replication with ilnti-rctroviral therilpy combinalions 
prolOllgS life and prevents opportunistic infections." 
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SO MUCH TO DO, SO LITTLE DONE 
infections, which usually occur after significant deterioration of an indivi-
duals' immune system, can be treated relatively effectively. It is the stated 
policy of the South African state to provide such appropriate treatment for 
opportunistic infections and the question of whether or not state policy 
and practice meet the constitutional benchmark is not discussed in this 
paper. Instead, the paper is concerned with the issue of providing access 
to anti-retroviral drugs, which are either administered to prevent HIV 
infection, or, if administered in the latter stages of the progression of the 
HIV virus (usually in stage four), to combat the virus and ensure the 
stabilisation of an individual's CD4 count. 
Anti-retroviral drugs can also be administered to individuals who might 
have been exposed to the virus in order to lower the chances of HIV 
infection. In such cases patients are usually given one dose or a short 
course of a particular anti-retroviral drug. When anti-retroviral drugs are 
administered as a treatment option, a patient is usually required to take a 
combination of at least three drugs. This therapy, usually referred to as 
Highly Active Anti-Retroviral Therapy (or HAART). 20 is capable of com-
pletely suppressing the replication of the virus within an HIV positive 
individual. With successful HAART treatment, the individual's immune 
system recovers with a consequent significant improvement in survival 
rates and life expectancy." HAART treatment is not appropriate for all 
people living with HIV and is usually only prescribed for individuals whose 
CD4 count has dipped below the 350 mark. 
3 THE CONSTITUTIONAL COURT AND THE RIGHT OF ACCESS 
TO HEALTH CARE 
3.1 Introduction 
The state's constitutional duty to provide individuals with access to anti-
retroviral drugs to prevent the transmission of H IV or to prevent the 
replication of HIV in the blood of a person living with HIV/AlDS, derives 
mainly from the right of access to health care services guaranteed in 
section 27 of the Bill of Rights." The Constitutional Court has had the 
opportunity to consider the scope and content of section 27 on two pre-
vious occasions." The Court has also provided extensive analysis of 
the nature of the duties that social and economic rights place on the 
state in the case of Government of the Republic of South Africa and Others v 
20 Hoffmann, supra nore 1 1, par 13. 
21 Ibid. See also US Health and Human Services, supra note 19. 
22 5 27 states: 
(I) Everyone has the right of access to -
(a) Health care services, including reproductive health care; 
(2) The state must take reasonable legislative and other measures, within its available 
resources, to achieve the progreSSive realisation of each of these rights. 
(3) No one may be refused emergency medical treatment. 
23 Soobramoney v Minister oj Health. KwaZulu-Natal 1998 (I) SA 765 (CC), 1997 (12) BCLR 
1696 (Ce) (hereafter Soobramoney); Minister oj Health and Others v Treatment Action 
Campaign and Others 2002 (5) SA 721 (ee). 2002 (10) BCLR 1033 (ee) (hereafter TAC). 
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LAW, DEMOCRACY & DEVELOPMENT 
Crootboom and Others" These judgments confirm that the right of access 
to health care services protected in section 27 of the Constitution is clearly 
justiciable," It also confirms that the constitutionality of state action or 
inaction must not be measured in the abstract, but in the light of the 
specific social and historical context of South Africa,' This context is one 
that recognises inequality and the vast disparities in wealth between rich 
and poor, Any understanding of the state's obligation to provide access to 
health care must therefore be rooted in an understanding that the Consti-
tution contains a commitment to address inequality, poverty and unem-
ployment in order to "transform our society into one in which there will 
be human dignity, freedom and equality", and that this "lies at the heart 
of our new constitutional order"," 
This means that in evaluating whether state action or inaction in pro-
viding access to anti-relroviral drugs will constitute an infringement of 
section 27, one has to take cognisance of: 
• the fact that many of South Africa's poorest citizens have little or no 
access to health care services, while many of the richest citizens have 
access to some of the best health care facilities in the world; 
• the fact that newly born children of poor parents do not have immedi-
ate access to life saving medicine; and 
• the magnitude of the HIV!AIDS crisis in South Africa and the dispropor-
tionate effect of this epidemic on the poor and marginalised sections of 
the community, 
It is clear that the nature of the state's obligations in providing access to 
health care in the HIV!AIDS field will be influenced by the severity of the 
crisis and the seriousness of the consequences of a failure to act appropri-
ately, What might have been reasonable and acceptable in an ordinary 
health crisis may become completely unreasonable - even irrational - in 
the face of a health crisis on the scale of that now facing South Africa as a 
consequence of HIV!AIDS, 
It is with reference to this specific context that I shall now distil the ba-
sic principles enunciated by the Constitutional Court regarding the en-
forcement of the right of access to health care, 
3.2 The duties engendered by the right of access to health care 
services 
3.2.1 Negative obligation on the part of the state and other role 
players to respect the right of access to health care 
Section 27 places a negative obligation on the state and other relevant 
role players to desist from preventing or impairing the right of access to 
24 Govf'rnment 0/ the Repu/JI1(' of'South A/rica (/nd Others v GroollJOom and Others 2001 (I) 
SA 4() (CC), 2000 (I I) B('UI 1 16Y (( C) (ilereaf[er Groo/iJoorn) 
25 Ex parte Chairpason of/he ConslitutlOnal Asseml)ly In lie Cem/ication oj the COllstltutlOn 
oj the liepul)11C a/South A/rICa, 1 ()<)6 (10) BC1.R 12')3 ICC) [Jdr 78 
26 GrootiJoom, supra nOIC 2,1, pilr 25; '1 AC, supra 1I0ll' 23, par 24 
27 Grootiworn, il)id quoting froll1 SooiJramoney, supra [101C 23, pdr H 
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SO MUCH TO DO, SO UTILE DONE 
health care services." Any action by the state that takes away existing 
access to health care services or makes it more difficult for an individual 
to gain access to existing health care services, would thus potentially 
result in an infringement of this right. In the context of providing access to 
anti-retroviral drugs for all people exposed to HIV or people living with 
HIV/AIDS, any action by the state to, say, prohibit doctors in either the 
public or private health sector from dispensing a specific anti-retroviral 
drug would constitute a prima facie infringement of the right. The nega-
tive aspect of this right is further spelt out in section 27(3), which states 
that no one may be refused emergency medical treatment. A person who 
suffers a sudden catastrophe - such as rape, for example that carries 
with it a threat of contracting HIV and that calls for immediate medical 
attention, should thus not be refused treatment where such treatment can 
be provided and is necessary to stabilise the patient's condition. 
3.2.2 The positive obligation on the state to protect, promote and 
fulfil the right of access to health care 
Section 27 of the Constitution places a positive obligation on the state and 
other relevant actors to "protect, promote and Fulfil" the right of access to 
health care services.3I What is reqUired is for the state to devise and 
implement a comprehensive plan to ensure full realisation of the right of 
access to health care for alt." This plan cannot merely be aimed at pro-
viding individuals with basic medicine, primary health care services and 
access to hospital care." Following a holistic approach, such a plan must 
be aimed at providing all South Africans with access to adequate, com-
prehensive health care that will enable them to live healthier and more 
productive lives.'4 Implicit in this approach is the understanding that the 
right of access to health care services does not entitle any applicant to 
individual relief in the sense of immediate access to adequate health 
care. 
28 Certification jUdgment, supra nme 25, par 20; Grootboom. supra note 24. par 34; TAC. 
supra note 23, par 46. 
29 See. for example. the recent case where an NCO that provided voluntary counselling 
and testing and anti-retroviral drugs to rape survivors was evicted from a state hospital 
in Nelspruit. Yende 200 I "Health MEC evicis anti-rape activists" < www.IO/.co.zal 
genera/lnewslnewsprintphp?arUd = ct200 / 05121740 I 3225R 136168 > 12 May. Accessed 
17 March 2002. 
30 In Soobramoney the Constitullona! Coun made clear that "emergency medica! treat-
ment" does not refer to any ongoing medical treatment for someone whose life is not 
immediately being threalened. Rather. it ensures that a person is treated in case of a 
medical emergency. Soobramoney, supra note 23, par 18 and 20. 
31 See s 7(2) which states that the state "must respect. protect, promote and fulfil the 
rights in the Bill of Rights." 
32 Grootboom, supra note 24, par .38 
33 Ibid par 35. where Ihe COUf[ stated that the right of access to housing "requires more 
than brick and mortaL" 
34 In the context of HIV/AII)S. what is required is access to primary health care services, to 
information about HIV. to voluntary testing and counselling faCilities. to provision of 
anri-retroviral drugs, etc. 
35 Grootboom, supra note 24, par 94-95. 
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LAW. DEMOCRACY & DEVELOPMENT 
When devising and implementing this plan, the state must take cogni-
sance of the conditions and capabillties of people of all economic levels of 
our SOCiety. '" Those who can afford to pay for health care should do so 
themselves, but where people have no money to pay, the state has a duty 
to take steps to unlock the system through legislation and other measures. 
The state must address the needs of both those who can afford health 
care and those who cannOL More importantly, the "poor are particularly 
vulnerable and their needs require special attention".'; 
However, the state's obligation in this regard is not unqualified. The 
extent of the state's obligation is defined by three key elements set out in 
section 27(2), namely: 
(I) whether legislative or mher measures are reasonable; 
(2) progressive realisation of the right, and 
(3) to do so within available resources. 
(1) The state must take reasonable legislative and other measures 
Courts must enqUire whether the steps taken by the state to meet its consti-
tutional obligations imposed by section 27 are reasonable. Such steps will 
be reasonable where they are based on coherent and comprehensive 
policies and pro&rammes that are reasonable both in their conception and 
implementation.' A reasonable plan might include the adoption of legisla-
tion invariably supported by appropriate, well-directed policies and pro-
grammes implemented by the executive. Such programmes must be 
determined by all three spheres of government and each sphere of gov-
ernment must accept responsibility for the implementation of particular 
pans of the programme. However, the national sphere of government must 
assume responsibility for ensuring that the laws, policies, programmes and 
strategies are adequate to meet the state's obligations. Such programmes 
must be capable of facilitating the realisation of the right and must be 
reasonable both in their conception and their implementation. The pro-
grammes must be "balanced and flexible". One that "excludes a significant 
segment of society cannot be said to be reasonable". 11' To be reasonable, 
measures cannot leave out of account the degree and the extent of the 
denial of the right they endeavour to realise. Those whose needs are the 
most urgent and whose ability to enjoy all rights are most in peril, must not 
be ignored by the measures aimed at achieving the realisation of the goal. 
Where measures, though statistically successful, fail to respond to those 
most desperate, they may not pass the test of reasonableness." 
(2) ProgreSSive realisation of the right 
The second requirement of progressive realisation signals that the right 
cannot be realised immediately. The state is nevertheless under a duty LO 
"16 fIJi!! par y, 
'37 11ii!! par ":i(), TAC, supra !lore 23, pdr 70 
38 Graul/}oom, supra 1100e 24. par 42. 
39 INri par ·10. 
40 Ibid par 43; TAC, supra !\()(e 21. par 6H. 
41 GraUl/mom. SIl/JrtI lIote 24, par 44; and TAe. supm Ilote 21. par 68 
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SO MUCH TO DO, SO LITTLE DONE 
begin to take steps immediately to progressively facilitate access to health 
care services as expeditiously and effectively as is reasonably possible. In 
effect this means that legal, administrative, operational and financial 
hurdles towards realising the right should be examined and, where possi-
ble, lowered over time. Health care must thus be made more accessible 
not only to a larger number of people, but also to a wider range of people 
as time progresses.42 Any deliberate retrogressive measures in that regard 
would also require the most careful consideration and would need to be 
fully justified by reference to the totality of the rights provided in the Bill 
of Rights. 43 
(3) Resource constraints 
To determine whether the state's action or inaction is reasonable, one has 
to take into account the resources available to realise the right in question. 
There always has to be a balance between goal and means. The measures 
have to be calculated to attain the goal expeditiously and effectively, but 
the availability of resources will always be an important factor in deter-
mining what was reasonable in a particular case." While it would be 
inappropriate for the Court to make orders directed at rearranging budg-
ets, a determination of the unreasonableness of state action or inaction 
might well have budgetary implications." Where resources are clearly 
insufficient to attain any meaningful access to certain forms of health 
care, a lack of action on the part of the state may be found to be reason-
able, compared with cases where the resource constraints are less severe. 
4 HIVIAIDS, ANTI-RETROVIRAL DRUGS AND THE STATE'S 
RESPONSE TO HIVIAIDS EPIDEMIC 
4.1 Introduction 
Anti-retroviral drugs can be used in at least two distinct ways. First, they 
can be used to prevent the transmission of the H IV virus in cases where 
individuals have been exposed to it in various circumstances. Second, 
anti-retroviral therapy can be administered to HIV positive individuals at 
an advanced stage of the progression of the HIV virus to suppress H IV 
viral activity and thus to prolong and improve the person's quality of life. 
In the following sections I deal with these two distinct issues separately, 
first mapping out the steps that the state has taken in providing access to 
anti-retroviral drugs in various situations and then evaluating these steps 
with reference to their Constitutional duties as set out in the previous 
section of this paper. 46 
42 Grootboom. supra note 24, par 44. 
43 ibid par. 45. 
44 ibid par 46. 
45 TAC, supra note 23, par 38. 
46 The government's policy is in flux and it is sometimes difficult to ascertain its exact 
nature and the steps taken to implement it. On 17 April 2002 - after the completion of 
a first draft of this paper - the Cabinet issued a statement in which it seems to indicate 
that several changes in government policy were in the pipeline. This statement was 
[continued on next page] 
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LAW, DEMOCRACY &. DEVELOPMENT 
4.2 Anti-retroviral therapy and the prevention of HIV infection 
4.2.1 Exposure of medical personnel to HIV 
(a) State response 
Health care workers are often exposed to HIV in the course of their duties 
and therefore often risk becoming HIV positive. Those whose work in-
volves blood collection or the use of sharp instruments such as needles. 
the insertion of intravenous catheters or minor or major surgery, are at 
increased risk of exposure to HIV. Although the risk is relatively low, the 
Department of Health has laid down clear guidelines to deal with it.~7 
According to the guidelines, the most effective way of dealing with high-
risk exposure is to administer a combination of anti-retroviral drugs 
within an hour or two after exposure." To avoid delays in starting this 
treatment, the guidelines recommend that starter packs of the relevant 
drugs be made available in all health care settings. The gUidelines also 
recommend that treatment be continued for up to four weeks after the 
incident. The policy also requires that supportive counselling be made 
available to the exposed health care worker.'" 
It is unclear whether the relevant drugs are always available in all health 
care settings. Anecdotal evidence suggests that adequate and appropriate 
storage facilities are not available at all state health care facilities and that 
the policy has not been implemented at some rural clinics. 
(b) Evaluation of the state's response 
Health care workers are in a special position, distinguishable from other 
people exposed to HIV. First, they are employed by the state and put 
themselves in harm's way in the ordinary course of their duties. Second, 
they form a relatively small group and the cost of providing them with 
access to anti-retroviral drugs is therefore minimal. Civen this context, a 
failure by the state to formulate and implement a policy providing health 
care workers exposed to HIV access to anti-retroviral drugs could well be 
considered unreasonable in the terms contemplated by section 27. This 
does not mean that the state is failing in fulfilling its constitutional duty if 
its policy does not provide every health care worker in the public health 
sector with access to a prophylactic regime of anti-retroviral drugs. After 
elaborated upon In d st,llenH,nt of Y October 2002. I sliall atlempt to provide an over-
view of the ctlanging governlTlent policy before evaluating ir in derail. See South Africa 
C()VCrrllllerlt Online 2002a "CatJint'l statelTlCllt on HIViAIJ)S" < WWw.gov.za/speeches/ 
cIII)ineIAIDS02.hlm> Accessed 17 April 2002; a Ill! South Africa Government Online 
2002b "COlltilluity and change in HIViAll)S poliCy" < WWw.gov.za/projerls/hiv/ 
hivpoliry02apr.hlm> Accessed t 7 April 2002. 
47 J)('partrTlent of lIealth 1'1'19 "Marlagr'nll'lll of olTllparional exposure to 1-11 V" 
< hltp:!/ 196. 36.fS 1.S6/doh/AJf)S > Accessed 20 Apnl 2002. 
48 The drugs prescriiled by the guidelines are Zidovudirli' (AZRl adlTlinistered in cOfnbina-
rion with Lalllivudine (3TC) It is reconliTiended that Illdinavir be added for very high 
risk eXJlosllr~s. ror eXillTiple wlll're high volumes or blood are involved. where a deep 
injury lias occurr(;d and ir till: SOllrce patient has been on Zidllvurlinc for longer than six 
Illontlls. See I )epartlTlent of Ilealtil 19'1(). si/pm note 47.10 -I I 
4'1 fl)ii! II. 
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SO MUCH TO DO, SO UTILE DONE 
all, the right in section 27 is not an individual right but a right to a reason-
able policy reasonably implemented. 
Thus, what is required is for the state to conceptualise and implement a 
flexible and comprehensive policy that will allow an ever-increasing 
number of health care workers an ever-widening access to anti-retroviral 
therapy after exposure to the virus. 
At present, all available evidence suggests that such a reasonable policy 
does exist and that it is being implemented reasonably, given the limited 
resources available for health care in South Africa. However, this conclu-
sion does not mean that the state has no further duty to improve the 
access of health care workers to anti-retroviral drugs. For example, if the 
state Fails to take any further steps to broaden access of anti-retroviral 
drugs not only to a larger number of health care workers but also to a 
wider range of workers in terms of their rank and geographical distribu-
tion, the reasonableness of its inaction in terms of the Constitution might 
well become an issue. Furthermore, if the state refuses in future to pro-
vide access to anti-retroviral therapy to health care workers exposed to 
HlV who previously had access to such treatment, this might well give rise 
to a constitutional issue as such a step might be interpreted as a deliberate 
retrogressive measure. 
4,2,2 Exposure to HIV through sexual assault 
(a) State response 
A victim of rape or another form of sexual assault runs the risk of being 
exposed to and infected with HIV. There is strong evidence that survivors 
of rape or sexual assault can substantially reduce their risk of infection by 
taking a course of anti-retroviral therapy immediately after the exposure 
and by continuing treatment for a further two to six weeks. Before the 
Cabinet statement of 17 April 2002, official state policy prohibited the 
provision of anti-retroviral drugs in state hospitals to the survivors of 
sexual assault. so In at least one province Mpumalanga the MEC for 
health went further, evicting a volunteer NGO from state hospital prem-
ises for providing anti-retroviral drugs such as AZT and 3TC to survivors of 
rape and sexual assault. s1 The Cabinet statement of 17 April 2002 has 
brought a change in this position. According to the new policy, in cases of 
sexual assault, "government will endeavour to provide a comprehen-
sive package of care for victims, including counselling, testing for HIV, 
50 See Baloyi S 2001 "Sorry. no drugs here" Independeru Online 17 December 
< www.iol.co.zalgenerallnewslnewsprint.php?arUd = ct200 112072020 14981 A6 J 618 > 
Accessed 13 February 2002; Clarke S 2001 "Ethical war looms after rape·baby AZR 
row" Independent Online 18 October < www.loi.co.lalgenerallnewsl 
newsprintphp7arUd = ct2001 101820274670B00022 > 
Accessed 13 February 2002. 
51 See Yende 2001, supra note 29. The MEC argued that the NGO. Greater Nelspruit Rape 
lruervemion Project (Grip) was undermining the ANC. embarrassing the Presideru and 
poisoning black patients She also argued that the was pUHing her Department in 
an awkward position because rape survivors .he province were demanding 
anri-retroviral drugs. 
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LAW, DEMOCRACY & DEVELOPMENT 
pregnancy and STDs" The policy also provides for counselling for survi-
vors of rape and sexual assault on the uses and dangers of anti-retroviral 
drugs, and for providing those who so choose with access [() the appropri-
ate anti-retroviral drugs in accordance wilh state guidelines and pro[()cols, 
The relevant pro[()cols were developed and distributed [() provinces by 
,vlay 2002 and by October of the same year implementation of the pro-
gramme had started. Additional funding was also provided for additional 
staff training, testing for HIV and the cost of the drugs themselves.'" 
(b) Evaluation of the state's response 
This change in the state's policy goes a long way [()wards satisfying the 
requirements of section 27 of the Constitution. The state now has a com-
prehensive and coherent policy aimed at progressively providing survivors 
of rape and other forms of sexual assault with access to anti-retroviral 
drugs. Because the state health care system lacks the necessary infrastruc-
ture," not all survivors of sexual assault will immediately gain access [() 
the requisite counselling and - where appropriate anti-retroviral drugs, 
But the policy provides for the progressive expansion of the programme, 
and funds have been earmarked for training additional staff and for the 
cost of the drugs. The policy allows those health care facilities where the 
requisite capacity already exists [() provide the service, thus reversing the 
illogical and unreasonable aspect of the previous policy. 
In the rAe case the Constitutional Court confirmed in the context of a 
mother-[()-child transmission (MTCT) prevention programme that a 
policy which prohibited the administration of a potentially lifesaving drug 
like Nevirapine in the state health care sector, in cases where the cost [() 
the state would be minimal and where the capacity to administer the drug 
existed, was inflexible and thus unreasonable, The present policy thus 
appears adequately flexible to ensure that survivors of sexual assault will 
progressively gain access to counselling and anti-relroviral drugs. 
The only potential problem with the new policy relates to the reqUire-
ment that access should not only be provided progreSSively to a larger 
number of people but also to a wider range of people. Thus, if over time 
- the policy succeeds in assisting more rape survivors to gain access to 
post-rape counselling and to anti-retroviral drugs, but some of the most 
vulnerable survivors of rape, such as rural women, are completely left 
behind, then the policy could become problematic and perhaps even 
unreasonable. In such a case the policy itself might be reasonable but its 
implementation might be considered [() be unreasonable. At this 
however, it is too early to judge [he reasonableness of the implementation 
of the new policy. 
52 See SOllth Africa Goverlllllem Online 2002a, supra note 46. 
53 South Africa Government Online 2002(' "Update on Cabinet'S statemem of 17 April 2002 
on tightll1g 11IV/AIDS. 9 Octoher 2002: Lend a hand in the caillpaign of hope against 
IIiV/AIDS" < WWw.!lov.za!issueslhiv!cabilletAIDS90rt02.hlm > Accessed 3 December 2002 
54 SOllie anu-retroviral drugs must be stored at spentk temperatUres to ensure their 
continued Heillth care proressioflals also need to be trained to ensure thilt the 
drugs are adrnirllstered correctly and safely. Many health care fdcilities might lack the 
necessary facilities or the trdined staff required to administN the drugs 
55 TAC. supra nore 23. par 80. 
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4.2.3 MTCT of HIV 
(a) The basic facts 
SO MUCH TO DO, SO LITTLE DONE 
MTCT of HIV is the primary source of HIV infection in young children. 
Over 90 % of children living with HIV in South Africa became infected 
because of the transmission of the virus from their mothers, The trans-
mission of HIV takes place during pregnancy, labour, delivery, or even 
after childbirth during breast-feeding, but the vast majority of infections 
occur close to or during delivery, and after childbirth because of breast-
feeding. In the absence of breast-feeding, about two-thirds of infections 
occur around the time of delivery, with the majority of the remaining 
infections occurring during the last two months of pregnancy. But in 
populations where breast-feeding is the norm. it accounts for more than a 
third of all transmissions. Other factors - although less important - also 
increase the risk of MTCT of HIV.58 Foetal trauma. for example. and pre-
mature birth. may also increase the chances of an infant born HIV nega-
tive becoming infected due to breast-feeding
54 
The number of infants infected with HIV can be significantly reduced by 
providing at least one dose of an anti-retroviral drug like Nevirapine to a 
pregnant mother during childbirth and to the infant shortly after birth.bo In 
addition to the use of anti-retroviral drugs. prevention of MTCT reqUires 
VOluntary counselling, testing and various support services, UNAI DS has 
also stressed that providing mothers with formula feed as a substitute for 
56 Department of Health 2000c "Prevention of mother-to-child HIV transmission and 
management of HIV positive pregnant woman" <http://196.36.153.56IdohIAIDSI> p 5. 
57 Joint United Nations Programme on HIV/AIDS 2000 "UNAIDS technical update 
Mother-to-child transmission of HIV" < www.unA/DSorglpublicationsldocumentslmrcti 
MTCTJU4doc> Accessed 21 Marct12002. 
58 These are: the immune status of the mother, the viral load of the mother. vitamin A 
deficiency, behavioural faclOrs such as cigarene smoking, drug taking and unprotected 
intercourse during pregnancy, placenta infections. and the mode of delivery of the 
baby, See Deparrment of Health 2000c, supra note 56, 6~ 7, 
59 Ibid 7. 
60 See Connor et al 1994. Lindergren et al (1999); Guay et at 1999: 354. The provision of 
anti-retroviral drugs to HIV positive mothers during pregnancy and at birth has become 
part of the generally accepted package of minimum care for treatrnem of HIV positive 
pregnant mothers all over the world. Thus, UNAIDS recommends that the "minimum 
standard package of care" for the treatment of HIV positive mothers and their children 
should include, in the first instance, preventative interventions in the form of some form 
of ami-retroviral drug. It recognises that the benefit of decreasing MTCT by administer-
ing such anti-retroviral drugs "greatly outweighs any theoretical concerns related to de-
velopment of drug resistance." UNAIDS acknowledges that it is not advisable to 
prescribe the regimen to be adopted, and thus allows for a choice [0 be made in the 
context of regional variations. panicularly in respect of the availability and quality of an-
tenatal care, affordability and concerns relating to practical implementation. See UN-
AIDS 2000 "Press release 2000: Preventing rnother-to-child HIV transmission: Technical 
experts recommend use of amiretroviral regimens beyond pilot projects" 
< www.unAIDSorglwhatsnewlpresslenglgeneva251000.html> 25 October. Accessed 
15 February 2002. See also Treatment Action Campaign (TAC) 200la "Bredell consen-
sus statement on the imperative to expand access to anti-metroviral (ART) medicines 
for adults and children with HIVIAIDS in South Africa" < www.tac.org.za > 19 November. 
Accessed 12 February 2002, 
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LAW. DEMOCRACY & DEVELOPMENT 
breast milk will further lower the transmission rate, but the absence 
of such a programme will not nullify the effects of an anti-retroviral 
programme.' I 
Although research has shown that some of these regimes are more ef-
fective than others, the most pertinent programme for South African use 
is associated with the drug marketed under the name Nevirapine by the 
pharmaceutical company, Boehringer Ingelheim. Nevirapine has been 
registered by the Medicines Control Council for use to reduce the risk of 
MTCT of HIV intrapartum - that is, in the mother's womb before delivery. 
Moreover, there is ample evidence that the drug could have some success 
even without administering it in courses over weeks or even months. 
(b) The state response 
Until the handing down of the Constitutional Court judgment in the rAC 
case, the state's policy towards the prevention of MTCT of HIV was con-
fusing and difficult to ascertain. The policy established 18 'research sites' -
two in each province - where Nevirapine would be provided to HIV positive 
pregnant mothers at childbirth,'" reaching about 10% of pregnant mothers 
in South Africa. The pilot sites were launched to assess the operational 
challenges inherent in introducing an anti-retroviral regimen for the reduc-
tion of vertical transmission in both rural and urban settings in South Africa. 
There was some confusion on behalf of the state about whether the sites 
were also launched to investigate the efficacy of Nevirapine.'" However, the 
policy placed an absolute ban on health care professionals in state health 
care facilities other than the 18 pilot sites from administering Nevirapine to 
HIV positive pregnant mothers."" This meant that mothers and their 
babies who could not afford private health care and did not have access to 
one of the pilot sites, could get no access to anti-rerroviral rrearmenL DS 
This policy was Challenged in the rAC case, where the Constitutional 
Court rejected the arguments put forward by the Ministry of Health and 
found the policy regarding MTCT of H IV to be unreasonable and thus 
unconstitutional. First, the state argued that it could not provide Nevira-
pine outside the pilot sites because of: 
• the lack of evidence regarding the efficacy of the drug; 
• 
• 
• 
the fear that the use of Nevirapine would lead to resistance in subjects; 
fears about the safety of the drug; and 
a lack of capacity to administer the drug in all state hospitals." 
61 UNAlI)S 2000. supra lIote 60. Tile UNAIDS recollllllcnlidiions ilisisl IhiH lile WOlllall 
herself should Illake the decisioll regarding breasl-feedillg. aller receivillg iliforlTlalioll 
011 the risks alld benefits 01 various feE'dilig oplions arid raking rhe specifics 01 her cir-
CUIllSlances into consideration. II' breast-feedirlg is indeed CllOS(;[l. exclusive breast-
leeding lor lhe tirst lTlonths of life is recolllillenckd. 10 be discorHinued when allerna-
tive lorrlls of feeding becolTle feasible. 
62 Ikpartlllenr of Ileallh200lb. slipra nOle 12. pM 1.3 See also Smith 2001 alld Mail & 
Guardian 200 I. 
63 See Business !Jay (200 I). 
64 See TAC. supra note 23. par 10- II 
65 JiJici par 17. 
(,6 JiJid pdt 51 54. 
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so MUCH TO DO. SO UTILE DONE 
The Court these reasons on the basis of evidence provided by, 
among others, the representatives of the state itself,67 and stated that the 
only question to be answered was whether or not the policy of confining 
Nevirapine to research and training sites was reasonable, 
The Court found that the policy was indeed unreasonable because it 
failed to address the needs of those mothers and their newborn children 
with no access to pilot sites. The policy failed to distinguish between the 
evaluation of programmes for reducing MTCT and the need to provide 
access to health care services required by those who do not have access to 
the sites. 6S The policy was therefore unreasonable because it was not 
balanced and flexible and it excluded a significant segment of society,69 
The state had not provided any cogent and reasonable explanation for 
their inflexible and unbalanced policy, considering that: 
• the case was concerned with newborn babies, whose lives might be 
saved by the administration of Nevirapine to mother and child at the 
time of birth; 
• the safety and efficacy of the drug for this purpose had been established; 
• the drug was being provided by the state itself to mothers and babies 
at pilot sites;?O and 
• the administration of Nevirapine is a simple procedure,' 
Furthermore, the Court pointed out that the right of access to health care 
had to be read with the right of children to family care or parental care 
and the right to basic health care services as set out in sections 28( 1 )(b) 
and (c), While the primary duty to provide basic health care services rests 
on those parents who can afford to pay for such services, the state policy 
had to address the needs of those children whose parents could not afford 
to do so, Echoing wording in the Grootboom judgment, the Court in the 
TAe case held that: 
Their needs are 'most urgent' and their inability to have access to Nevirapine 
profoundly affects their ability to enjoy all rights to which they are entitled. 
Their rights are 'most in peril' as a result of the policy that has been adopted 
and are most affected by a rigid and inflexible policy that excludes them from 
having access to Nevirapine n 
The Court argued that the second question whether the state had a 
comprehensive plan to combat MTCT of HIV - was intertwined with the 
refusal to permit Nevirapine to be prescribed at public hospitals and 
clinics outside the research sites. After evaluating the relevant evidence, 
the Court found the measures taken by the state in respect of the preven-
tion of MTCT of HIV were unreasonable. Although health services in South 
Africa are over-extended and although HIV is just one of many illnesses 
67 Ibid par 57-66. 
68 Ibid par 67. 
69 Ibid par 68. 
70 Ibid par 72. 
71 Ibid par 73. 
72 Ibid par 78. 
73 Ibid par 82. 
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LAW, DEMOCRACY & DEVELOPMENT 
that require attention, the HIV pandemic is of such a serious nature that 
the state has a constitutional duty to act. The Court held as follows: 
The rigidity of government's approach when these proceedings commenced 
affected its policy as a whole. If. as we have held, It was not reasonable ro re-
strict the use of Nevirapine to the research and training sites, the poliCy as a 
whole will have to be reviewed. Hospitals and clinics that have testing and 
counselling facilities should be able to prescribe Nevirapine where that is medi-
cally indicated. The training of counsellors ought now to include training for 
counselling on the use of Nevirapine. As previously indicated, this is not a com-
plex task and it should not be difficult to equip counsellors with the 
necessary additional knowledge. In addition, government will need to take rea-
sonable measures to extend the testing and counselling facilities to hospitals 
and clinics throughout the public health sector beyond the test sites to facilitate 
and expedite the use of Nevirapin<:, for the purpose of reducing the risk of 
mother-to-child transmission of H IV" 
The Court therefore ordered the state: 
• to immediately remove the restrictions preventing Nevirapine from 
being made available for the purposes of reducing MTCT of HIV; 
• to permit and facilitate the use of Nevirapine for the purpose of re-
ducing the risk of MTCT of HIV; 
• to make provision if necessary for counsellors based at public hospitals 
and clinics other than the pilot sites to be trained for the counselling 
necessary for the use of Nevirapine to reduce the risk of MTCT of HIV; 
and finally, 
• to take reasonable measures to extend the testing and counselling 
facilities at hospitals and clinics throughout the public health sector to 
facilitate and expedite the use of Nevirapine for the purpose of reduc-
ing the risks of MTCT of HIV." 
The Court stressed that these orders did not preclude the state from 
adapting its policy in a manner consistent with the Constitution if equally 
appropriate or better methods became available to it for the prevention of 
MTCT of HIV. At the same time the Court also made clear that the order 
did not leave the state with a choice as to which hospitals and clinics 
should be 'allowed' to prescribe Nevirapine. The choice was left in the 
hands of the medical practitioners acting in consultation with the medical 
superintendent of the facility concerned. 
The Constitutional Court judgment was pre-empted to some degree by 
an announcement by the Cabinet on I 7 April 2002 that signalled an 
apparent change of heart on the part of the state. This statement con-
firmed that the state would begin to provide anti-retroviral drugs to HIV 
pOSitive pregnant women as required by the High Court judgment. It also 
stated that "where there is capacity to provide the package of care that is 
needed, and where the demands of research dictate, [pilot! sites are being 
extended". The statement also indicated that towards the end of 2002, 
tests would be done on the babies while mothers would be monitored, 
74 Ibid par 95. 
75 I/)id peH 135. 
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SO MUCH TO 00, SO LITTLE DONE 
and the results would determine whether the state would move to provide 
universal access of Nevirapine. A universal rollout plan in this regard was 
being worked on and would be released in due course?6 This statement 
was followed up by another Cabinet statement on 9 October 2002 in 
which the state confirmed that, following the Constitutional Court ruling, 
all provinces had been provided with guidelines for the implementation of 
the Prevention of Mother-To-Child Transmission (PMTCT) package. Ac-
cording to the statement, provinces would "expand the services according 
to their differing capacities, but training is already in progress in all prov-
inces to broaden access to Nevirapine".77 The statement suggested that no 
universal roll out was envisaged in the near future and that each province 
would gradually broaden access to Nevirapine as facilities, budgets and 
human capacity allow. 
(c) Evaluating the state's response 
The state's response to the TAC judgment suggests that it has changed its 
policies regarding the prevention of MTCT of HIV to fall in line with the 
requirements set out by the Court. It has provided provinces with guide-
lines for implementing MTCT prevention programmes. However, it is left 
to each individual province to devise and implement a rollout plan, taking 
into account its own capacity. The national government will only playa 
monitoring role in overseeing the implementation of this plan. It has lifted 
the ban on providing Nevirapine outside the pilot sites and is overseeing 
the training of counsellors. The policy therefore appears less rigid and 
more balanced and flexible and is beginning to address the needs of those 
most at peril. On the face of it, the policy and the steps taken so far to 
implement it seem, at the time of writing, to be reasonable and in line 
with the state's constitutional duties as set out by section 27. 
However, as Grootboom made clear, the national government has the 
final responsibility for ensuring that the action taken is adequate to meet 
the state's constitutional requirements. The fact that individual provinces 
are left to devise their own rollout plans may therefore become problem-
atic where implementation of the programme in individual provinces falls 
short of what is constitutionally required. An ongoing evaluation of the 
state's programme will therefore have to focus on the way in which the 
programme is implemented in the various provinces, While KwaZulu-
Natal and the Western Province have extended coverage to a significant 
number of pregnant women, other provinces, such as Mpumalanga and 
the Eastern Cape, are lagging behind." It will be recalled that the reason-
ableness of the state's response will be assessed not only with reference 
to the formulation of the plan, but also its implementation. The state's 
response will also fall short where it broadens access of pregnant women to 
Nevirapine, but fails to address the needs of those most in need. If prov-
inces such as the Eastern Cape and Mpumalanga fail to make significant 
76 South Africa Government Online (2002a), supra note 46. 
77 South Africa Government Online (2002c), supra note 53. 
78 SABCnews 2002 "TAC calls on Mpumalanga to roll out Nevirapine" < www.sabcnews.com/ 
south_africa/health/O,I 009,484 I 9.00.hrml > Accessed 17 January 2003. 
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LAW. DEMOCRACY & DEVELOPMENT 
progress with the design and implementation of programmes to prevent 
MTCT within a reasonable period of time, such inaction may well give rise 
to further constitutional complaints, including possible contempt of court 
charges.'» It would then have to be established whether these provinces 
are failing to take constitutionally mandated reasonable steps to provide 
access to Nevirapine to HIV positive pregnant women and their unborn 
children. Such failure could either involve not extending access to women 
and children who are most in need, or not devising and implementing a 
balanced and flexible programme that would allow for extension over time. 
4.3 Access to anti-retroviral therapy and the treatment of HIV 
positive individuals 
4.3.1 The background facts 
South Africa's ability to deal effectively with the human drama unfolding 
in the light of the spiralling H IV/AI DS crisis will depend. to a large degree. 
on whether the majority of those living with the virus are able [Q gain 
access to essential drugs for both inhibiting the virus and treating the 
opportunistic infections associated with it. All available credible evidence 
indicates that HAART anti-retroviral therapy can improve and prolong the 
quality of life of most people living with HIV/AIDS. People living with HIV 
do not generally become prone to opportunistic infections until HIV pro-
to the stage where the CD4 + cells per micro litre of blood drop 
below 500. When those living with HIV are successfully treated with a 
cocktail of anti-retroviral drugs. the progreSSion of HIV is dramatically 
altered. In many cases. this results in a marked improvement in the 
CD4 + count with a concomitant improvement in the survival rate and in 
life expectancy. Successful treatment leads to a prolonged and healthier 
life along with a reduction in vulnerability to opportunistic infections. 
The Department of Health guidelines indicate that while people who 
suffer from opportunistic infections related to H IV will be treated in state 
hospitals. they will not be provided with any access to anti-retroviral 
drugs.' HAART therapy is therefore only available to individuals with 
access to private health care and the means to pay for it. In this section 
of the paper I will explore if and how the state could broaden access to 
HAART therapy for those who need it. I will first looh. at the state's current 
response before evaluating it in the light of the state's constitutional 
commitments. 
79 T/\(, 2002 "TAC launches urgenl COlllerl1pr of COllrt applicalion against Mpumalallga 
ll"alrh MEC" < WWW((lc.oryzall1ews[etterlns/7_'2_2002hrml> .Accessed 17 January 
2003. 
80 Whiteside elill 2000: 6b. 
HI IkparrrnerH ()f Health 2()0 J I). supra flOte 12. par 2.1 
82 {bill pdr 2.2. Even imlividllals who have access to medical aid cannot always anuni 
HI\MH Illerapy When rhese drugs were first introduced. the cost for Sourh Africans 
who could afford it was arollnd R4 000 per lIlonlh At pre"ent the cost for such lreat-
IIlCIliS IS between R600 and R 1 000 per mom h Se" I~lack 2001 
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so MUCH TO DO, SO UTILE DONE 
4.3.2 The state's response 
The state has endorsed the view that anti-retroviral treatments can help 
improve the condition of people living with HIV!AIDS. At the same time it 
has pointed out that these drugs are, at present, too costly for universal 
access, while incorrect use of them could cause harm.8J In its statement of 
17 April 2002, the Cabinet committed itself to "continue to work for the 
lowering of the cost of these drugs" 84 In October it confirmed that the 
ultimate objective was to ensure that all South Africans living with AIDS 
could have access to the treatment they needed under conditions that 
would benefit them.ss In order to achieve this goal, the state would need 
to strengthen the health care system while also taking steps to lower the 
cost of drugs, the single biggest barrier to cheaper prices being the strict 
enforcement of patents. Sb Where this enforcement takes place, drug 
companies are free to charge the prices they wish. In the absence of 
drastic state intervention the prices of life-saving drugs - including anti-
retrovirals - will thus remain out of reach of most South Africans. 
The state took the first steps towards lowering the costs of drugs in 
1997 when it adopted the Medicines and Related Substances Amendment 
Act.
s7 
This legislation amended the Medicines Act, allowing the introduc-
tion of three measures that would be important in bringing down the 
price of drugs. First, the amendments made provision for the generic 
substitution of off-patent medicines and medicines imported and pro-
duced under compulsory licenses. This means the Act compels pharma-
cists to prescribe a cheaper generic version of a medicine, if one exists, 
when presented with a prescription by a patient. Generic medicines are 
83 South Africa Government Online 2002c, supra note 53. For a discussion of additional 
barriers, see Rozek et at 1999: 81). The authors argue that "in many instances. the 
prices of pharmaceuticals are not the cause of access problems. If the patient does not 
have access to a physician. or lacks accurate information. prices are irrelevant." While 
the affordability of drugs is clearly nor the only barrier to effective treatment. what re-
mains clear is that, for as long as drugs remain out of reach for most people with 
HIV/AIDS. governments have little incentive to put systems in place to deal with effi-
cient distribution and strict compliance with often complicated drug-taking regimes. 
Further. for as long as drugs remain inaccessible. the debate about tlealth system infra-
structure remains purely academic. In addition, for many people with HIV/AIDS high 
drug prices are the only or at least most important obstacle in the way of access to 
treatment. Of course. one may also argue that any comprehensive and adequate pro-
gramme to progreSSively provide access to HIV/AIDS treatment and care programmes 
will act as a catalyst to the development of health infrastructure. This is an important 
point, but cannot be discussed further in the context of this paper. 
84 South Africa Government Online 2002a. supra note 46. 
85 South Africa Government Online 2002c. supra note 53. 
86 Brazil remains the clearest example of this point. For further information on the 
correlation between weaker patent protections and increased access to essential drugs. 
see Rosenberg 2001. The pharmaceutical industry argues that patents are not the 
problem with access to AIDS drugs in the developing world because the infrastructure is 
not available and circumstances are too chaotic to make drug delivery realistic. But this 
is a simplistic view. especially in a country like South Africa where the required infra-
structure does exist in many places 
87 Act 90 of 1997 amending the Medicines and Related Substances Control Act 101 of 
1965. 
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LAW, DEMOCRACY & DEVELOPMENT 
usually produced when the patent on a drug has lapsed, As most anti-
retroviral drugs are still protected by patent, this provision will not have 
any great effect on the cost of anti-retroviral drugs, Second, the Act 
amended the Medicines Control Act to allow for the parallel importation of 
patented medicines'
c 
This measure allows the state to import patented 
medicines from countries where they are sold at a lower price than in 
South Africa, Because pharmaceutical companies do not charge the same 
price for identical drugs in different countries, this section would allow the 
state to import patent-protected drugs from countries like India and Brazil, 
for example, at a cheaper price than the relevant pharmaceutical com-
pany charges in South AFrica, 
Third, the amendments provide for a transparent medicine pricing sys-
tem through the establishment of a pricing committee, This section re-
quires pharmaceutical companies to justify the prices they charge and 
empowers the pricing committee to make recommendations to the Minis-
ter of Health on the introduction of a transparent pricing system ,"0 
All three provisions were challenged by 39 pharmaceutical companies 
in the Transvaal Provincial Division of the High Court towards the end of 
2000, in The Pharmaceutical Manufacturers' Association and Others v The 
President of the Republic of South Africa and Others,"' The pharmaceutical 
companies challenged the constitutionality of the three provisions of the 
Act as set out above, inter alia, on the basis that they infringe on the 
right to property protected in section 25 of South Africa's Constitution. 
Under severe public pressure in South Africa and the rest of the world, 
the companies abandoned their case and in effect agreed that the state 
had a right to implement the provisions set out above v, At the time of 
writing, the state had not yet issued regulations to make these sections 
of the amendments operative and had therefore neither started to 
import cheaper patented drugs from elsewhere nor begun to regulate 
the pricing of drugs. Nor had it taken any other tangible measures in any 
attempt to bring down the prices of anti-retroviral and other life-saVing 
drugs. 
I:ll:l See "lilC ~OO I b "All explanation of Ihe Medicints Au and Ihe implicaliollS or the COLIrt 
Victory" < www.tac.org.za > 24 ApriL Accessf:d 26 April :WO I. While many key anti-
n:lroviral drugs used in the nglll dgalrlSt fllVIAI DS i1rc still subject 10 patem prolCuion 
for a rHlIlltJer of years, fhe patents OIl others, such as Pfizer's Diflucan (fluconazole) and 
Glaxo Sl1lilllKline's Rf'lrovir (zidovudine or AZTl. are nearing expiration 
89 Act '1001 1997. s 15C 
90 Ibid s 22(;. 
91 The Pharrnilcelllical ,1'v1an!l/c{clllrers' Association and Others v The President 0/ the HepubJic 
of'South Af'rim and Others Case no. 4183i'J1:l, High COLIrt of South Mrica (Transvaal Pro-
vincial iJivision) March ~oo I. 
92 Ii hilS been ilfgued that this withdrawal by rhe phannacellrical companies WdS a good 
tactical move as tht, al1lemimcnts tiley had challenged - including the amendmenr that 
would provide for parallel illlporling of cheaper drugs frorn elsewhere were not par-
ticulMly Ihreattnillg to tlleir profits and interests. Whar pharmaceutical companies fear 
1ll0St, so tile argllll1e1l1 goes. is legislation that allows for the issuing of compulsory li-
cem:es by fhe state to enable orller manufilCiurers lO IllanuiaClllre patented drugs. 
l~os(~Jl!Jerg 2001 
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SO MUCH TO DO, SO LITTLE DONE 
4.3.3 Evaluation of the state's response 
South African courts will be hesitant to interfere with the state programme 
to extend access to anti-retroviral treatment to all South Africans who 
need it - even where the steps taken by the state seem uninspiring and 
lacking in urgency. Providing access to HAART-type treatment is a complex 
issue, requiring a nuanced and well thought out response from the state. 
Any such programme will also have enormous implications for the alloca-
tion of resources by the state. It would therefore be difficult - but not 
impossible - to demonstrate failure by the state in its constitutional duty to 
take reasonable steps to progressively provide access to HAART therapy to 
a larger number and a wider range of people living with HIV/AIDS. 
When evaluating state action or inaction, one will have to address at 
least three interrelated aspects in order to begin to make a case that the 
state has failed to take reasonable measures to provide access to health 
care in terms of section 27 of the Constitution. First, one will have to 
demonstrate that, given the state's wide array of health commitments, 
special emphasis should be placed on the provision of HAART therapy. 
Second, one will have to show that the latent capacity exists in at least 
part of the public health system to oversee the implementation of such a 
system and provide support to ensure the continued success of such ther-
apy. Third, one will have to determine whether the cost of providing access 
to anti-retroviral therapy to all people living with HIV in South Africa, who 
are unable to afford it, would be within the state's available resources. I 
will deal with these three issues separately in the following sections. 
(a) The importance of HAART therapy 
Given the serious personal and public consequences of the HIV/AIDS 
epidemic, the life-prolonging nature of HAART therapy and the mitigating 
effect of HAART therapy on the burgeoning social problems associated 
with the epidemic - such as the problems associated with taking care of 
AIDS orphans - it will not be too difficult to demonstrate the therapy's 
importance. As the introduction of HAART therapy will literally prolong 
the lives of hundreds of thousands of South Africans, who will thus remain 
economically productive and capable of taking care of their loved ones, 
HAART therapy becomes a life or death issue. The importance of HAART 
therapy can furthermore be illustrated with reference to international 
human rights law. In its General Comment No. 14, the United Nations 
Committee on Economic, Social and Cultural Rights (CESCR) set out "core 
obligations" for states parties in relation to the right to "the highest attain-
able standard of health" protected in article 12 of the International Cove-
nant on Economic, Social and Cultural Rights (ICESCR). One such 
obligation was to provide all individuals in a state with access to essential 
dru~s, as defined in the World Health Organisation (WHO) essential drugs 
list. ) This list, updated every two years, sets out those drugs that are 
considered essential to meet the health care needs of the majority of the 
93 General Cornmenr No. 14 (Twenty-second session, 2000) The right to the highest artaill-
able standard of health (art 12 of the Covenant) UN doc. E/C.12/2000/4, par 43 (d). 
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population and which are supposed to be available at all times in ade-
quate amounts and in appropriate dosage form."4 At the 12th meeting of 
the Expert Committee on the Selection and Use of Essential Medicines, 
anti-retroviral medicines were included in the essential drugs list and the 
prescription of combination anti-retroviral therapy was endorsed. The 
use of combinations of three to four different anti-retroviral drugs was 
strongly recommended in treatment guidelines for H IV/AI DS in resource 
poor settings. 
This means that access to HAART therapy becomes part of the 'mini-
mum core' entitlements in international law. Where a court in South Africa 
is called upon to evaluate the reasonableness of the steps taken by the 
state in broadening access to anti-retroviral drugs for all South Africans, 
the fact that the provision of such drugs forms part of the minimum core 
obligations of a state may have an impact on the assessment of the rea-
sonableness of the state's conduct."" Although the Court did not imply that 
that minimum core entitlement would affect the burden of proof in order 
to show the reasonableness of the states' action, it did confirm that it is 
one of the factors to be taken into account when assessing the reason-
ableness of the state's response. Reasonableness will have to be assessed 
with reference to all relevant factors, including those mentioned in the 
previous paragraph. Taken together, all these factors strongly suggests 
that the state has a special duty to take steps to provide anti-retroviral 
drugs to a larger and wider group of those who neeci it. 
(b) Lack of capacity 
It is often argued that administering anti-retroviral therapy makes very 
specific demands on the public health system. As the drugs are only 
successful If taken at the correct times and in dosages appropriate for the 
specific patient, a plan aimed at successfully implementing the provision 
of anti-retroviral drugs to people who are HIV positive will have to have a 
number of components. These include: 
• training health providers on the appropriate use of the drugs; 
• provision of laboratory facilities to regularly monitor the effect of the 
drugs in order to tailor therapy to individual patients; 
• establishing the appropriate infrastructure to procure and safely dis-
tribute these drugs; and 
• creating a supportive environment to facilitate compliance with the 
therapy by patients. ,,' 
It is furthermore argued that successfully implementing such an anti-
retroviral therapy regime is particularly difficult in a developing country 
<)1 See World Healill Organisdlion (WIIO) 2002a "The WIIO lisl of esseclIiill drugs (EDl. 19'1<))" 
< WWlV. whu.ini/medicines/ur!fimizatiun/pilr/edllinfedimaill.shimi > Accessed 22 May 2002 
95 See WHO 20021l "12tll Expert Comrnittee on tile Selection dCHi Use of Essenrial Medicines 
llIeeting. 15- 19 April 2002" < wwwwho.inl/medicines/U/:janiZillion/pllr/edU 
expf'rlnOif's.shlmi> Accessed 22 May 2002. 
<)6 rAe. Slipru note 23. par 34. 
(J7 Departlllent of I Icaltil 200 I Il. supra note 12. par 2.2 
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like South Africa because many patients are uneducated and will find it 
difficult to take their medication as prescribed, This can, in turn, lead to 
toxic side effects and can do patients more harm than good. 
Despite the complexity of the various regimens and the many side ef-
fects associated with anti-retroviral drugs, and despite the infrastructural 
requirements, anti-retroviral drugs can play an important role in the 
effective treatment of people living with HIV and AIDS in South Africa. 
Data from two major HIV trial sites demonstrate that high levels of adher-
ence are achievable by South African patients. These studies show that 
levels of adherence were as good as, or better than, that attained in many 
first world countries." Furthermore, innovative treatment options are 
being used for resource-poor settings. 
Given these facts, it becomes clear that the state may well have a duty 
to begin the process of progressively providing access to anti-retroviral 
therapy to people living with HlV/AlDS. A comprehensive, multi-layered 
plan is needed, along with steps to ensure its effective implementation. 
Such a plan must progreSSively provide access to HAART treatment to 
people living with HIV and AIDS. Although the state may argue that it 
would be more reasonable to roll out in areas where infrastructure to 
monitor usage is more developed, any plan will also have to begin to 
address the needs of those most vulnerable and least capable of gaining 
access themselves: poor, black, often female individuals living in rural 
areas of South Africa. A constitutionally valid plan would have to engage 
with the issues raised above and would have to begin to address the 
infrastructure and capacity issues that constitute barriers to the provision 
of HAART therapy. The state cannot be expected to immediately improve 
the public health system to the extent that it is capable of providing and 
overseeing a comprehensive anti-retroviral therapy programme for all 
those in need. However, it can be expected to factor these problems into 
planning and budgeting processes to demonstrate that it is taking reason-
able steps to gear the public health system towards coping with this 
national emergency. Failure to do anything would, on its own, be seen as 
unreasonable and would compromise the constitutionality of the state's 
health policy. The costs of such improvements to the state's public health 
capacity are not irrelevant and the Court would probably accord the state 
a wide margin of discretion in implementing any policy geared towards 
addressing the national emergency resulting from the HIV/AIDS crisis. 
However, this does not mean that the state cannot be held constitutionally 
accountable for a failure to take reasonable steps to improve its capacity 
to provide anti-retroviral therapy in the public health sector. 
In many state hospitals the necessary capacity already exists to provide 
a full support service to people on anti-retroviral therapy. I therefore 
conclude that the state has a duty to take steps to progressively extend 
that capacity to other areas where none exists to ensure that it is equita-
bly distributed. Where especially marginalised and vulnerable people have 
no chance of gaining access to a state health care facility that does have 
98 Abdullah et al 200 I. 
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capacity. state action should prioritise those areas. The first requirement is 
a clear indication that state public health care plans include provision for 
greater access by all South Africans to health care facilities where anti-
retroviral therapy could be provided and monitored. The second is that 
this plan also targets those most in need of access to treatment. 
(c) The cost of anti-retroviral drugs 
By all accounts the cost of anti-retroviral drug therapy is high."" The De-
partment of Health argues that. at current prices. these drugs are not 
affordable and hence they have no choice but to stick to the policy of not 
providing access to anti-retroviral therapy to people living with HlV!AIDS. 
In legal terms, the argument could be framed as follows: While the state 
has a duty to take reasonable legislative and other measures to progres-
sively provide individuals living with HIV!AIDS access to health care, anti-
retroviral therapy is so expensive that the state cannot afford it at aiL It 
would therefore be senseless to take any measures to progressively pro-
vide access to anti-retroviral drugs. as (he state will never be able to afford 
to provide them to all. It would be unfair and unreasonable to provide 
such drugs only to some people, so it is more equitable not to provide 
them (0 anyone. All the state can afford to do is to treat the opportunistic 
infections that occur due to the weakening of the immune system of 
individual people living with HIV!AIDS. 
There are, however. two lines of reasoning that may be pursued to chal-
lenge this view. One relates to the cost effectiveness of anti-retroviral 
therapy and the other to steps that could be taken to lower the cost of the 
drugs themselves. 
• The cost effectiveness of anti-retroviral therapy: It has been argued, 
qUite convincingly, that the provision of anti-retroviral drugs in the 
public health system will be cost effective as it will bring about vast 
savings in the costs of treating HIV positive individuals. Two different 
studies, published in the New England Journal oj Medicine in March 
200 I, demonstrate that anti-retroviral drugs can be cost-effective in 
comparison to the medical treatment of people with full-blown AIDS. I." 
Brazil's nationwide anti-retroviral treatment programme is based on 
the findings that the direct savings achieved in keeping people healthy 
compensates for the cost of the drugs. These studies are based on the 
assumption that people who succumb to opportunistic infections will 
have access to adequate. humane and effective treatment in the public 
health system, something to which the South African government is 
commirred. 'u, If it can indeed be conclusively shown that it is cost ef-
fective to provide anti-retroviral therapy rather than merely to wait for 
people [Q fall ill and then to treat their opportunistic infections. the 
'1'/ supra 110[(0 80. 
100 Freedberg el al 200 I. Bouelle ('/ ,/1200 I. 
101 In praClic e. of course. this policy does not illeiln lilal SHcll adf'quale tredllnem is 
provided 10 all WtlO need it While the DepilrtIlH'!H 01 I t"dltlt's [Joliey guidelines 
tor sllch [rea[lTlf'rH. tack of funds ilnd bad fllilnagelllPllI of len lead 10 a situation 
wl1f:re the requisite [reallnenr is not available in Slate hospitals. 
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so MUCH TO DO, SO LITTLE DONE 
Failure to work towards the provision of anti-retroviral therapy For all 
people who may Fall back on the public health system for treatment 
would clearly be unreasonable, if not irrational. In the context of the 
life and death choices that these two options present, the unreasonable 
nature of any failure to act in this regard will become even more ap-
parent. 
• Lowering of drug prices: While the cost of anti-retroviral therapy is 
currently very high, the state could take steps to ensure it is lowered. 
This will enable more middle-income people with access to private 
health care to access anti-retroviral therapy. It will also reduce the cost 
of providing anti-retroviral therapy in the public health sector, where it 
may enable progressive access to such therapy. As indicated above, 
the biggest stumbling block to providing more people with better ac-
cess to anti-retroviral therapy remains high drug prices, mainly due to 
the strict enforcement of patents. There are two interrelated reasons for 
this: First, domestic laws dealing with patents may be formulated 
strictly, making it difficult for a country to provide cheaper alternatives 
to drugs priced at the high end of the market by name-brand pharma-
ceutical companies. Second, even where governments are willing to 
weaken patent laws to ensure cheaper medicines, the World Trade Or-
ganization (WTO) agreement on intellectual property rights - commonly 
known as TRIPS'0' - has strengthened the international protection of 
such rights to effectively narrow the scope of national patent policies.,o4 
But the state can take steps within the existing national and international 
patent law framework to influence the price of drugs This can be done, 
first, through direct regulatory mechanisms, including price controls on 
the sale of pharmaceutical products and the parallel importation of pat-
ented products From where they are sold at the lowest international price. 
This is exactly what the state attempted to do when it passed the 
amendments to the Medicines Control Act discussed above. However, 
they have not yet issued the requisite regulations allowing for the parallel 
importation of cheaper generic versions of drugs. 
The existing (amended) legislation allows for action that could drasti-
cally reduce the prices of anti-retroviral drugs, and thereby progressively 
facilitate access to affordable anti-retroviral drugs by individuals living 
with HIV/AIDS. The state's failure to act in terms of this legislation seems 
deeply unreasonable. In the absence of credible reasons for this delay, the 
state's inaction could be found to be in breach of its constitutional duties 
in terms of section 27. 
102 A Similar argument was raised in the rAe case, but the Court decided that it was not 
necessary [0 deal with it because the government had changed its poliCies already and 
had committed substantial additional resources [0 the treatment of HIV. rAe. supra 
note 23. par 120. 
103 General Agreement on Tariffs and Trade Multilateral trade negotiations (the 
round): Agreement on Trade-related Aspects of Intellectual Propeny Rights (15 )pr,~mil)pr 
1993J. (1994) 33 LLM. 81 (TRIPS) 
104 For example. pre-TRIPS Brazil completely excluded pharmaceutical produ(;[s from 
patentability. See generally Berger 200 I. 
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Second, drug prices can also be reduced through indirect means, Such 
indirect price regulatory mechanisms can make use of market processes 
by introducing real competition in the drugs market in the form of generic 
manufacturers, This can be done in three distinct ways: 
I. The state could take steps to allow for the issuing of compulsory 
licenses, A compulsory license is an authorisation to use a patent 
without the patent holder's permission."" In most cases, such licences 
will be issued to other companies who would have to pay an agreed 
fee to the patent holder for the right to produce a generic version of 
the drug, However, this fee will be drastically lower than the profit the 
patent holder drug company would have made otherwise. 
2, The state could take steps to allow early working provisions to be put 
in place, Early working provisions ensure the introduction of 
copies of a patented product to the marketplace as soon as patent 
protection expires, by permitting certain forms of conduct that would 
otherwise constitute patent infringement. 
3, The state could take steps to exclude certain drugs from patentability, 
This means the patent law will allow specific drugs to be precluded 
from being granted full patent protection in the First place in speCific, 
well-defined circumstances such as public health emergencies, 
It is unclear whether South African patent lawC< allows for the issuing of 
compulsory licenses for the production of anti-retroviral drugs, The Patent 
Act contains a provision that allows for limited opportunities to bypass the 
patent rights of the patent holder, Article 56 permits abrogation of patents 
only where: 
• the patent is not being worked on a commercial scale or to an ade-
quate extent; 
• the demand is not being met adequately: 
• the trade or industry of the Republic is being prejudiced; or 
• the price for the patented article is excessive compared to its price 
elsewhere, ",'I 
10') Ford 2000, 942, III the pllannaceUlical sec[Or, a LOlllpulsory license entitles tile licenseE: 
[0 l1lillluliluure generic versions 01' a paH'fl!!'d drug or 10 import such products fro/ll 
wlwre they are legally IlIilllut'actul't,d, eltller by [Iw lin'I1see itsel! or by anotlier generrc 
lllal1LllaCiurer 
106 Patents Act 56 of 1978 
107 Article 56 of the Parents Au stdles [h,lI Ihe rights in d patenr shall be deemed to be 
abused it 
108 
(il) tile pilt(;nted invtmioll is not lwing woriled in the 1{('Pllblic Otl a cofllll1enial scale 
or to an adequdte ext('flr. aiu,r the expiry of a ppriot/ 01 lour years subsequent to 
tile date of the appill'iltioll lor the patent or tllree sllb~eqlll::'l1t 10 the date on 
whicil that WdS sealed. whit hever period and there is in lile 
opinion of commiSSioner no satisfactory rt'd~OIl fur sue nOIl-woriling; 
(b) 
(e) the demand For the pa[l'fHcd article in the Hepuhllc is 1101 llt-ing Illel [0 an adequdte 
(;xterll dnd on reasonable terms; 
(ll) tly r(,clson of Ihe refusal of rile patentee to grail! d 11<:('11'>(; or licenses UPOIl rea'>orl-
able rerms. tll(; trade or industry or agriculture 01 tlit, l{epuLJII( or the trilde 01 <lny 
person or ddSS of persons trading in tile: I{cpuhlic. or the estatJlislmWfll 01 dlly new 
Icol1tinueci on nex( 1}(1f/<'j 
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so MUCH TO DO. SO LITTLE DONE 
While the last exception may conceivably be used to justify the issuing of 
compulsory licences. this might lead to protracted court battles akin to the 
one fought by 39 pharmaceutical companies against the government 
regarding the amendments to the Medicines Control Act. In any event. the 
state has not taken any steps to utilise the patent law in this way as it has 
so far refused to consider any expansion of these restrictions. 
The only possible reason for this lack of action on the part of the state -
apart from a lack of political will - is its alleged obligations in terms of 
international trade law. The TRIPS Accord. an international intellectual 
property rights agreement to which South Africa is a signatory. imposes 
minimum standards of intellectual property protection on all signatories. '0" 
TRIPS also expressly allows for the imposition of weaker patent protection 
in certain circumstances. 'oo Although legal avenues for bypassing patent 
rights therefore do exist. and have been used by many countries for 
relatively trivial inventions. there has been strong pressure on developing 
countries from the pharmaceutical industry not to use these provisions to 
access generic versions of anti-retroviral drugs. But the recent agreement 
by the Ministerial Conference of the World Trade Organisation in Doha. 
Qatar. broke new ground. when representatives decisively confirmed that 
countries should have a right to make exceptions to the TRI PS agreement. 
including the issuing of compulsory licenses. if a national emergency 
exists. According to the agreement. a national emergency includes a 
public health crisis. such as the one related to HIV/AIDS. liD This Ministerial 
agreement explains the provisions of article 31 of the TRIPS agreement 
that do allow for the issuing of compulsory licences if certain criteria are 
met. A country will therefore comply with its TRIPS obligations even when 
it issues a compulsory license to manufacture anti-retroviral drugs at 
prices far cheaper than the prices the original patent holder might have 
charged. provided that it is acting in accordance with the requirements set 
out in article 31 and because of a national health emergency. These 
trade or industry in the Republic. is being prejudiced. and it is in the public interest 
that a license or licenses should be granted: or 
(e) the demand in the Republic for the patented article is being met by importation and 
the price charged by the patentee 
108 World Trade Organization (WTO) 2000 "Overview: The TRIPS agreement" < www.wto.orgl 
englishltratopJltrips_elinteI2J.htm> Accessed 20 July 200 I . 
109 See. for example. articles 27. 30 and 31. 
I 10 See article 31 of TRIPS accord read with article 5 of WTO 2002 "Declaration on the 
TRIPS agreement and public health" < www.docsonline.wto.org> Accessed on 22 April 
2002, which states: 
(a) 
(b) Each Member has the right to grant compulsory licences and the freedom to 
determine the grounds upon which such licences are granted. 
(c) Each Member has the right to determine what constitutes a national emergency or 
other circumstances of extreme urgency, it being understood that public health cri-
sis, including tllOse related to HIV/AIDS, tuberculosis. malaria and other epidemics, 
can represent a national emergency or other circumstances of extreme urgency. 
(d) The effect of the provisions in the TRIPS agreelllent that are relevant to the exhaus-
tion of intellectual property rights is to leave each Member free LO establish its own 
regime for such exhaustion without challenge, subject to the MFN and national 
treatment provisions of Articles 3 and 4. 
109 
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LAW. DEMOCRACY & DEVELOPMENT 
requirements centre around the need to utilise the drugs manufactured in 
terms of the issuing of compulsory licences mainly for the domestic market 
and to adequately remunerate the original patent holder." However, [he 
1 I I Ani( Ie 31 Olher u;e willlOUI alullOrizdliol1 01 Ihe paltlll holder (COlnpulsory lICensing). 
J JO 
Wliere llie law of a Melnber allows lor oilier usr~ 01 rile subJeCl Inaner of d palenl 
wllhoul Ihe authorization of the right holder. including use by tile government or lhirt! 
parties aUlhurized by the governrllenL 11iE' followillg provisions shall be respected: 
(a) aUlliorizatiol1 of slich llse shall be considered Oil ils H1cjividuallllerils; 
(I)) SIKh lise IlldY only 1)(' perlllitied iL prior to suci] lise. the propose(l user lias made 
efforis 10 obtain dlllhorizdlion frolll Ihe holder 011 reasonable comillercial 
IUIllS and ("ondilions and thai sllch efiorls not bl:en successlul withlfl a rea-
sonaille period 01 lime. This requircllH'nt iIlay be waiwd by d MelnlJer in the Ci!o,C 
of a national ernerg(~ncy or orher circumsrances oj" E'XlreIlH~ urgency or in case" of 
public non-commercial use. In SillldtlOIlS 01 lIational or other circLlIII-
"tances of (:xlretnc urgency. Ihe right holder shiill. notified as soon 
as reasorlilbly praclicablt:. In tht: case of public nO[l'corlllllt'rcialllse, where Ihc gov-
ernlllcnt or coni ractor, withour nldking it palerll search. knows or has dernonslrable 
grounds [() know {hat a valid palenr is or willlJe used lly or for rhe goverrnnerll, the 
right 110Ider shall be informed promplly. 
(e) Ihe scope and dural ion of Silch lise shall be limited to the purpose for which it was 
auth(llized. and in Ihe cast' of setlli-cotltluCiOr wclHl()logy shall (lIlly ile lor public 
IIOll-COfl1rIWrcial Llse or to rernerly a practice determined after judicial or admillis, 
Irallve process 10 he dIlIi-competitive; 
(d) such US(: sliall be lion-exclusive: 
(e) silch use sliall be nOfI-assign"hle. excepl willi 111,\1 pilri of I lie enterprise or goodwill 
which enjoys Silch liS": 
(l) any silch llse shall be dUliI<lrized predominanlly for the supply of the domestic 
market of (he IVkl11ber authoriling such lise: 
(1';> autllOriz<Hioll for slich use shall be liable, subjeCi 10 adequdte protectioll of (Ile 
legitimare illlcresis of Itle persu[ls su alJlhori!.cd. to !J(. lerrllinated if and when the 
CirCllll1stdllces which led 10 it cedse to exisl and drt: llllllkl>ly to recur. The compe-
tellt iHllhurilY shall hav(! Ille aUltlOrity 10 reVI(,w. upon IllOlivClteil [(;<juesl, the con-
tinued cxistence Df liles(' cirnunsldllcCS: 
(Ii) the riglll holder shall he paid adeqlldte remuneralion in thE' circuillstances 01 each 
case, laking illlo aCCOLJr1! 11lE' e( ortornic value of the aUlllorizatiort; 
(i) llie h·gdl validity 01 any decisioll r""lIing (() tilt> alilhorizatioll 01 slIcil lise sllall be 
~ut)JeCi 10 judicial review or oll1(;r indepclldem review hy il dislinct higher aUlhorily 
in tllilt M('llIbcr: 
(j) any decision relaling to Ihe relllllllt!ralion provided in re~peCi of such U~(, shall be 
slliljccl to jlldiciill review or otlier independent review by il disl inc! hIgher authority 
in !llat Member; 
(k) Ml:r1Ibers arc nOi oblig(:d to apply tile conditions set forth ill subparagraphs (b) and 
(I'j where such use is penTlille(j to rCIlIPdy a prdctice del ermined artE'l judicial or 
ildmiliistrrttive pron:ss [0 be anti-compelitive. The need to correct anti-compelitive 
practices llIay Ile taken into acc[)unl in determining the amount of remuneralion ill 
slich cases Cornpeletll authorities shall have tilt' authority to refuse termination of 
(lulhurizalion It and when the conditions which led 10 such authorization arc likely 
to recur; 
(!) wllere such use b auti1orlzt'(j to permit the exploilation or a patent ('tlie sCClllld 
p(ltelll') which cannot ht: explOited without infringing another patent ('Ihe lirsl pal-
Cllt'). Ihe following il(iditiwldl conditions shall dPply: 
(Ill) Ihe inwlIlion claimed in tile sc(ond pah'nf Slid II involve an imporralll technical 
advann' oj considerable economic significance in relalion iO the invention clainwli 
in tilt! nrSI patent. 
(11) lilt' owner or the nrst patPIH shall be cillilled [() a Closs-licence 011 l'casonable lerms 
to use (ile invention claimed ill Ihe second patE'111; and 
[confirmed on neXf pa!v! 
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SO MUCH TO DO, SO LITTLE DONE 
Doha agreement makes clear that in the case of emergencies, such as the 
HIV/AIADS crisis, member states have a wide discretion and have the final 
say about the interpretation of these requirements as long as they act in 
terms of their own domestic law. This leaves the state with an almost 
unlimited discretion in issuing compulsory licences, for remuneration as 
determined by the state."! The state's failure to make use of these provi-
sions and to take steps to allow For the issuing of compulsory licences for 
manufacturing anti-retroviral drugs in South Africa is indeed perplexing. It 
has neither taken steps to shorten the time within which it would become 
acceptable to manufacture certain generic drugs, nor has it done anything 
that would allow for the issuing of compulsory licenses for manufacturing 
anti-retroviral drugs. 
The test in terms of section 27, as always, is whether the actions or 
omissions of the state can be said to be reasonable, given the specific 
context. Given the catastrophiC nature of the HIV/AIDS epidemic and the 
life and death emergency under which its actions should be judged, it is 
my contention that the state is not acting reasonably in this regard. Its 
Failure to take steps allowing for the compulsory issuing of licenses to 
manufacture life-saving anti-retroviral drugs at prices that would make 
them affordable to all seems, in the present context, not only unreason-
able but irrational. 
5 CONCLUSION 
The state has failed to comply with its obligations to provide South Afri-
cans with access to anti-retroviral drugs in several ways. While section 27 
of the Constitution does not require the state to provide anti-retroviral 
drugs to all South Africans on demand, it does require it to take reason-
able steps to move towards a situation where all South Africans will have 
access to such drugs. In doing so, it has a special responsibility to include 
steps to begin to address the Fact that it is the most vulnerable sections of 
the population - poor people, women, people living in rural areas, black 
people - who have the least access to anti-retroviral drugs, yet are most at 
risk of becoming HIV positive. 
What has been lacking in the state's conduct is the sense of urgency, a 
sense that this is a life and death situation that requires immediate and 
drastic measures. In the absence of any such measures, many of the 
state's policies could be challenged both politically and legally for being 
unreasonable. 
(0) the use authorized in respect of the first patent shall be non-assignable except with 
the aSSignment of the second patent. 
I 12 Although an agreement was reached that patents on Hlv. TB ilnd malaria drugs could be 
broken. there was no as to which other conditions should receive similar exemp-
tion. Negotiations to with these outstanding issues broke down late in 2002. If a senle-
ment is not reached. senior World Trade Organisation officials warn that any agreements 
reached in the current round of talks, including the Doha deal in late 200 I, which seemed [Q 
allow access to generics in the event of "health emergencies", would be nullified. AIOSmap 
2003 "'Mass murder by complacency' attacked by UN HIV envoy as WTO talks restart" 
< www.A/DSmap.comlnewslnewsdisplay2.asp?newsJd = J 832 > Accessed I 7 January 2003. 
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